SCHEMBL5757545

SCHEMBL5757545

CN(CCOc1ccc(C(=O)NO)cc1)C(=O)c1c[nH]c2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 6/20 0.51
HDAC6 Q9UBN7 6/20 0.51
IGF1R P08069 1/20 0.48
MET P08581 1/20 0.48
CDK4 P11802 7/20 0.48
CCND1 P24385 7/20 0.48
MAPT P10636 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
KMT2A Q03164 1/20 0.47
TP53 P04637 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
BCHE P06276 1/20 0.45
ACHE P22303 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL445121 0.81 MAPT (0.61) HDAC1HDAC6IGF1RMETCDK4
SCHEMBL5760400 0.78 PDGFRB (0.55) HDAC1HDAC6MEN1NPC1RAB9A
SCHEMBL27649282 0.77 GBA1 (0.46) HDAC1HDAC6RAB9ABCHEACHE
SCHEMBL27275913 0.75 CDK4 (0.58) CDK4CCND1
SCHEMBL445847 0.72 HDAC1 (0.57) HDAC1HDAC6CDK4CCND1MAPT
SCHEMBL4251688 0.72 MAPT (0.58) HDAC1HDAC6MAPTSMN1; SMN2MEN1
SCHEMBL13763424 0.72 PBRM1 (0.58) CDK4CCND1SMN1; SMN2KMT2ATP53
SCHEMBL9036635 0.72 CDK4 (0.43) CDK4CCND1MEN1NPC1KMT2A
SCHEMBL10648144 0.72 SMN1; SMN2 (0.69) MAPTSMN1; SMN2MEN1NPC1RAB9A
SCHEMBL9688745 0.71 CDK4 (0.45) CDK4CCND1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006042035-A2 METHOD OF MONITORING ANTI-TUMOR ACTIVITY OF AN HDAC INHIBITOR PHARMACYCLICS, INC. (US) 2006-04-20 WO disclosed
EP-1611088-A2 HYDROXAMATES AS THERAPEUTIC AGENTS AXYS PHARMACEUTICALS, INC. (US) 2006-01-04 EP disclosed
WO-2004092115-A2 HYDROXAMATES AS THERAPEUTIC AGENTS AXYS PHARMACEUTICALS INC. (US) 2004-10-28 WO disclosed